DAVID J WOODHOUSE
CIK 1642995 · Chief Executive Officer · last filed 2026-05-14
DAVID J WOODHOUSE is a Chief Executive Officer who has filed 14 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for SRZNW, was dated May 14, 2026. Across all open-market trades the lifetime net is −$300.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
14
-$300.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRZNW | Director | — | $0.02 | — | $0 | 5 | 2026-05-14 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Chief Executive Officer | 0 | $1.54 | $0 | -$300.3K | 9 | 2024-04-08 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2024-04-08 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | −121,647 | $0 | EDGAR |
| 2024-01-18 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Tax (F) | −13,032 | -$17.5K | EDGAR |
| 2023-11-08 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | — | $0 | EDGAR |
| 2023-05-19 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2023-03-06 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | +127,200 | $0 | EDGAR |
| 2022-06-09 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |